GammaTile is an FDA approved treatment for brain tumors that is implanted at the time of surgery (both newly diagnosed or recurrent) and can double the time before the tumor grows, which buys time for other treatments to work.
It is not available everywhere just yet, visit their website to see which centers are using it now and ask your neurosurgeon about it.
This free webinar will go into detail about it.
Posted on: 01/27/2021
Learn More About GammaTile® Therapy, Surgically Targeted Radiation Therapy For Brain Tumors, At Patient Education Event On Thursday, February 4
, the latest advancement in brain tumor treatment, is implanted at the time of brain tumor removal surgery and allows patients to receive a therapeutic dose of radiation as they go about their daily lives.
TEMPE, Ariz. – January 27, 2021 – GT Medical Technologies, Inc. today announced a patient education event hosted in partnership with the Central New Jersey Brain Tumor Support Group and the Musella Foundation on Thursday, February 4 at 7 PM Eastern Time. Register here
for the event.
This virtual webinar will feature presentations by Dr. D. Jay McCracken, Head of Neurosurgical Oncology at the Piedmont Brain Tumor Center in Atlanta, Georgia, and Shannan Achens, a brain tumor survivor and GammaTile Patient Navigator.
Patricia Anthony, RN, BSN, CNRN
Head of the Central NJ Brain Tumor Support Group
Neuro-Oncology Nurse Clinician
JFK Brain Tumor Center
Hackensack Meridian Health
D. Jay McCracken, MD
Head of Neurosurgical Oncology
Co-Director of Piedmont Brain Tumor Center
Piedmont Atlanta Hospital
GammaTile Patient Navigator
Kansas City, Kansas
Topic: GammaTile Therapy | Surgically Targeted Radiation Therapy for Brain Tumors
I. GammaTile Therapy Overview
b. Types of Patients Who Can Benefit
c. Clinical Evidence
d. How To Get GammaTile
II. Shannan’s Story | GammaTile Therapy Treatment Experience And Outcome
III. Patient Q&A
About GT Medical Technologies, Inc.
Driven to overcome the limitations of current treatments for brain tumors and raise the standard of care, a team of brain tumor specialists joined forces and formed GT Medical Technologies with a purpose of improving the lives of patients with brain tumors. Its GammaTile Therapy received FDA 510(k) regulatory clearance for the treatment of all types of recurrent brain tumors and newly diagnosed malignant tumors. Patients receive their course of radiation while going about their daily lives, requiring no additional trips to the hospital or clinic for radiation therapy. GammaTile is available in top brain tumor centers across the United States. For more information or to find a GammaTile center near you, visit https://www.gtmedtech.com/
and follow @GTMedTech on Twitter
Click HERE to return to brain tumor news headlines.